Myopia Control Spectacle Lens Cessation Study

N/AActive Not RecruitingNCT05893979

SightGlass Vision, Inc.90 enrolled

Overview

To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Myopia Myopia Progression Juvenile Myopia

Interventions

Spectacle LensesDEVICE

Standard Spectacle Lenses

Eligibility

Sex: ALLMin age: 9 YearsMax age: 16 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Previously a successfully completed participant in the CYPRESS Extension study; * Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day); * Willingness to participate in the trial for up to 12 months without contact lens wear; * The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form. Exclusion Criteria: * Known allergy to proparacaine, tetracaine, or tropicamide.

Locations (8)

Golden Optometric Group

Whittier, California, United States

Omega Vision Center PA

Longwood, Florida, United States

Kannarr Eye Care

Pittsburg, Kansas, United States

Advanced Eyecare PC

Raytown, Missouri, United States

Outcomes

Primary Outcomes

Cycloplegic Spherical Equivalent Refraction (cSER)

Change in cSER

Time frame: 12 months

Secondary Outcomes

Cycloplegic Spherical Equivalent Refraction (cSER)

Change in cSER

Time frame: 6 months

Axial Length (AL)

Change in AL

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.